Search results
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
Medscape· 3 days agoThe novel investigational antipsychotic KarXT was effective and well tolerated in adults with ...
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
Clinical Trials Arena via Yahoo Finance· 1 day agoSubcutaneous OLAnzapine Extended-Release Injection Study (SOLARIS) trial’s efficacy portion...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 1 day agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
Ex-prisoner who stabbed grandfather to death days after release detained indefinitely
The Independent via Yahoo News· 6 hours agoThe 45-year-old, of no fixed address, denied murder but admitted manslaughter by diminished...
NeuShen begins dosing for Phase I trial of schizophrenia treatment
Clinical Trials Arena via Yahoo Finance· 2 days agoNeuShen Therapeutics has dosed the first healthy volunteer in Australia, marking the start of a...
Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 2 days agoShares of Teva Pharmaceutical Industries were climbing yet again on Wednesday, after the company...
‘Girl, Interrupted’ Cast Was Divided Into Factions, Elisabeth Moss Claims
Deadline via Yahoo News· 18 hours agoElisabeth Moss has spilled some tea on the behind-the-scenes of the 1999 film Girl, Interrupted....
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
Motley Fool via Yahoo Finance· 8 hours agoAnd last year it announced plans to acquire Cerevel Therapeutics for $8.7 billion (the deal remains...
Bill Waybourn, your deputies need you. Show the video in Tarrant County jail death | Opinion
Fort Worth Star-Telegram McClatchy via AOL· 6 hours agoPolice said Johnson was standing in the street with a knife. His family said he wanted to be treated...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 1 day agoThere's a theme to Neurocrine Biosciences' work, he told Investor's Business Daily. "(Neurocrine...